Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows.
Interesting Highlights From Today's 52-Week Lows
Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
Janux Therapeutics’s Return On Capital Employed Overview
Janux Therapeutics (NASDAQ:JANX) brought in sales totaling $1.62 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 24.61%, resulting in a loss of $13.42 million.
48 Biggest Movers From Friday
Gainers
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by AstraZeneca for patients with unresectable, stage 3 non-small cell lung cancer.
Janux Therapeutics Q2 EPS $(0.62) Up From $(2.76) YoY, Sales $482.00K
Janux Therapeutics (NASDAQ:JANX) reported quarterly losses of $(0.62) per share. This is a 77.54 percent increase over losses of $(2.76) per share from the same period last year. The company reported $482.00 thousand in
B of A Securities Initiates Coverage On Janux Therapeutics with Buy Rating, Announces Price Target of $35
B of A Securities analyst Geoff Meacham initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Buy rating and announces Price Target of $35.
The Week Ahead In Biotech: Focus On Chemocentryx FDA Decision, Conference Presentations In A Light Week
Biotech stocks advanced for a second week in running, with stocks reacting to pending releases for the second quarter and the first-half of the year.
The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 15)